Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
european medicines agency
2
×
fda
life sciences
national blog main
national top stories
akcea therapeutics
alnylam pharmaceuticals
avapritinib
biotech
blueprint medicines
clinical trials
cstone pharmaceuticals
deals
drugs
eli lilly
fisogatinib
flatiron health
genentech
harvard pilgrim health care
hepatocellular carcinoma
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
investing
jeff albers
medullary thyroid cancer
new york blog main
new york top stories
non-small cell lung cancer
onpattro
patisiran
pfizer
pralsetinib
roche
san diego blog main
san diego top stories
san francisco blog main
What
drug
fda
2
×
alnylam
approval
approves
blueprint
cancer
candidate
cells
currently
ema
employ
europe
follows
gene
harmful
hits
interference
make
marketing
medicine
medicines
method
muscle
mute
pact
protein
regulatory
ret
review
rna
rnai
roche
team
uses
way
wins
Language
unset
Current search:
fda
×
boston
×
" european medicines agency "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
